openPR Logo
Press release

Head & Neck Cancer Drug Market Increase in Use of Combination Therapy and Growth in Demand for Target Immune Therapy Are Expected To Boost the Market Growth in the Coming Years

04-02-2019 10:51 AM CET | Health & Medicine

Press release from: Allied Market Research

Head & Neck Cancer Drug Market

Head & Neck Cancer Drug Market

The Global Head & Neck Cancer drug market is estimated at $ 1,295 million in 2017 and is expected to reach $ 228.1 million by 2025, an annual average growth rate of 7.3% from 2018 to 2025.

Head and neck cancer drugs include chemotherapy and targeted & immunotherapeutic agents, which are used alone or in combination for treatment of the throat, larynx, nose, sinus, lips, salivary glands and oral cavity. The market for head and neck cancer treatment is expected to increase significantly more than expected due to the increase in the number of patients, increase in demand for combination therapies, progress in screening and diagnosis, and pipeline drug launches. For example, Ipilimumab, Atezolizumab, Avelumab, Durvalumab, Erlotinib, Afatinib and Bevacizumab.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/5174

Based on drug class, the global head & neck cancer drugs market is categorized as chemotherapy agents, immunotherapy, and targeted therapy. Chemotherapy was the major revenue contributing segment in 2017, due to increase in adoption of chemotherapeutics for treatment of head & neck cancer along with radiation therapy and rise in demand for combination therapy. However, the market for immune therapeutic drugs is projected to exhibit the fastest market growth during the forecast period owing to strong presence of pipeline drugs, rise in usage of Yervoy & Keytruda along with the supportive reimbursement policies for usage of immunotherapy drugs in some countries.

According to sales channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online stores. Currently, drug stores & retail pharmacies segment is major revenue contributor due to massive presence of these pharmacies. However, online providers segment is expected to show fastest market growth over the forecast period due to rise in preference for online purchasing of drugs over the traditional methods and increase in awareness about online pharmacy with rise in number of internet users.

Flat 20% Discount on All Type of License (https://www.alliedmarketresearch.com/checkout/93456 ) * Offer Valid Till 20th April 2019

Key Findings of the Head & Neck Cancer Drugs Market:

Based on sales channel, the online stores segment is expected to experience fastest market and is projected to grow at a CAGR of 10.2% during the forecast period 2018-2025.

Depending on drug class, the chemotherapy segment held nearly half of the global market share in 2017, and is projected to grow at a CAGR of 4.0% from 2018 to 2025.

Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 9.7% during the forecast period.

North America accounted for nearly one-half of the global market share in 2017, and is expected to remain dominant throughout the forecast period. This was attributed to higher demand for head & neck cancer drugs, higher number target population, favorable reimbursement policies in healthcare system, increase in number of trained medical professionals with wide availability of the advance therapeutics. However, Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to growing prevalence of head & neck cancer, upsurge in demand for head & neck cancer drugs with improvement in healthcare infrastructure.

Access Full Summery @ https://www.alliedmarketresearch.com/head-and-neck-cancer-drugs-market

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Contact:

David Correa

5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States

Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975

help@alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Head & Neck Cancer Drug Market Increase in Use of Combination Therapy and Growth in Demand for Target Immune Therapy Are Expected To Boost the Market Growth in the Coming Years here

News-ID: 1682941 • Views: 166

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Head

OMA Group Moves Head Office
Sharjah, United Arab Emirates, October 2018: OMA Group recently announced its move to their new office building premises which is just behind King Faisal Mosque in Sharjah, UAE occupying an area of 60,000 sq ft. As part of the Al Owais Group of Companies, OMA Emirates along with other subsidiaries of the group would now work under one roof. This move was a part of their expansion strategy
Global Well Head Equipment Market (2018-2023)
Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Wellhead Equipment Market. The Wellhead equipment market report has been segmented on the basis of Equipment Type (Master Valve, Hanger, Flanges, Choke and Others), By Application (Onshore, Offshore), By Market Types (O.E.M, Aftermarket), By Region (North America, Europe, Asia Pacific, LAMEA) and
Automotive Head-up Display
The Insight Partners added “Automotive Head-up Display (HUD) Market to 2025 - Global Analysis and Forecasts by Product Type, Sales Channel and Vehicle Type” to its research database. The report is spread across 150 pages and supported by 10 company leaders. Head up display in automotive is a transparent display which projects data on the wind-shield without requiring drivers to change their viewpoint. This is primarily achieved by two approaches. First,
New Head of Engineering
BBB Umwelttechnik GmbH strengthens its engineering department with Tarkan Pulur who is a qualified civil engineer. The new head of engineering is 36 years old and has already gained considerable experiences in the field of wind farm implementation. Pulur, who was born in Turkey acquired a degree in civil engineering at Bochum University. During the last years he worked for a major German turbine manufacturer as project and construction site manager
dinCloud Earns Top Marks in Head-to-Head Comparison
The #1 Brand in Hosted Virtual Desktops LOS ANGELES, CA – June 19, 2012 – dinCloud, a cloud transformation company and provider of hosted virtual desktops, has come out on top as the leading provider of DaaS (Desktop as a Service) in a head-to-head comparison of five market leaders by ExtremeLabs. dinCloud’s solution received the groupings highest marks for the solution’s good control, as well as fast response, and was the
Satish Babu to head ICFOSS
Trivandrum, Kerala, India, February 28, 2011 - The President of InApp, Mr. Satish Babu, has been appointed as the Director of the International Centre for Free and Open Source software (ICFOSS) by the Government of Kerala. The official inauguration of ICFOSS was done by Sri. V. S. Achuthanandan, Chief Minister of Kerala in Technopark on February 24, 2011. Ishita Roy IAS, Director, Kerala State IT Mission, and other dignitaries from Technopark